Skip to main content
Pamela Hsu, MD, Cardiology, Vancouver, WA

PamelaYuen-FenHsuMD

Cardiology Vancouver, WA

Adult Congenital Heart Disease

Physician

Are you Dr. Hsu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 51 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    700 NE 87th Ave
    Vancouver, WA 98664
    Phone+1 360-882-2778
    Fax+1 360-604-1753

Summary

  • Dr. Pamela Hsu, MD is a cardiologist in Vancouver, Washington. She is currently licensed to practice medicine in Washington, Arizona, and California. She is affiliated with PeaceHealth Southwest Medical Center.

Education & Training

  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Cardiovascular Disease, 2000 - 2003
  • Kaiser Permanente Northern California (Oakland)
    Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 1997 - 2000
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineInternship, Transitional Year, 1996 - 1997
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineClass of 1996

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2004 - Present
  • CA State Medical License
    CA State Medical License 1998 - Present
  • NM State Medical License
    NM State Medical License 1996 - 2027
  • WA State Medical License
    WA State Medical License 2014 - 2019
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Press Mentions

  • Characterizing the Belinostat Response in Patients with Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
    Characterizing the Belinostat Response in Patients with Relapsed or Refractory Angioimmunoblastic T-cell LymphomaNovember 9th, 2019